15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 5 firms covering Anheuser Busch Inbev NV ADR, 4 rate it Buy or better, 1 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. Targets are tightly clustered, $84.50 to $100.00, so the covering firms are broadly aligned. The average target of $92.07 sits 11% above the current $83.19. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 3 to 4 over recent months. On the fundamentals, the Street sees consensus EPS building from about $1.17 next quarter toward $4.91 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS5 ratings
Strong Buy
Strong Buy00%
Buy480%
Hold120%
Sell00%
Strong Sell00%
Based on 5 analysts giving stock ratings to Anheuser Busch Inbev NV ADR.
As of Jul, 4 of 5 firms rate BUD a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
BUD EPS & revenue forecast
EPS · NEXT QUARTER
$1.17
Range $1.13 – $1.21 · 3 analysts · +18% YoY
Next period, 3 analysts expect Anheuser Busch Inbev NV ADR to earn $1.17 a share (range $1.13 – $1.21), versus $0.99 a year earlier. Full-year consensus is $4.39, growing to $4.91 the year after.
REVENUE · NEXT QUARTER
$16.3B
Range $16.1B – $16.4B · 3 analysts · +7% YoY
Revenue is expected to reach $16.3B (range $16.1B – $16.4B), +7.5% year-over-year. Full-year consensus is $64.3B, rising to $66.9B next year.
Top analysts covering Anheuser Busch Inbev NV ADR
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on BUD.
#1
SS
Sarah Simon
Morgan Stanley
Buy
$84.50+1.6% to target
Coverage
—
+ Follow
#2
Chris Carey
Wells Fargo
Buy
$93.00+11.8% to target
Coverage
—
+ Follow
#3
Robert Ottenstein
Evercore ISI Group
Buy
$105.00+26.2% to target
Coverage
—
+ Follow
#4
ON
Olivier Nicolai
Goldman Sachs
Buy
$94.00+13.0% to target
Coverage
—
+ Follow
#5
AP
Andrea Pistacchi
Bank of America Securities
Buy
$95.00+14.2% to target
Coverage
—
+ Follow
BUD stock forecast FAQ
What is BUD's average 12-month price target?+
The 5 analysts with a live target average $92.07 for Anheuser Busch Inbev NV ADR over the next 12 months, ranging from a $100.00 high to a $84.50 low.
Is BUD stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 5 analyst ratings, 4 are Buy or Strong Buy, 1 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for BUD?+
The Street-high target is $100.00 (Evercore ISI Group), and the Street-low is $84.50 (Morgan Stanley). The average of all 5 active targets is $92.07.
How many Wall Street analysts cover BUD?+
5 analysts have an active rating on Anheuser Busch Inbev NV ADR, and 5 firms carry a live 12-month price target.
Who is the most accurate analyst covering BUD?+
Among analysts who currently cover BUD, Sarah Simon of Morgan Stanley has the strongest overall Quantellect track record. Their current call is Buy with a $84.50 target.
What is Anheuser Busch Inbev NV ADR's projected EPS for next quarter?+
The consensus estimate is $1.17 per share (range $1.13 – $1.21) across 3 analysts. Full-year EPS is projected at $4.39, rising to $4.91 the following year.
How much revenue is Anheuser Busch Inbev NV ADR expected to report next quarter?+
Consensus revenue is $16.3B (range $16.1B – $16.4B). Full-year revenue is projected at $64.3B, growing to $66.9B next year.
Have analysts been upgrading or downgrading BUD lately?+
As of Jul, 4 of 5 firms rate BUD a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their BUD calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
